For a clinical research study, what assessments can be done virtually? The short answer is – more than you might think. While not all clinical trial endpoints can be adapted to a virtual mode, many can be adapted to a virtual setting. This is particularly important during the COVID-19 pandemic, where reducing exposure for patients as much as possible remains critical to patient safety. Even if not all assessments can be done virtually, reducing exposure time by completing assessments at home should be the goal of all clinical trials.
5 Fast Facts about Clinical Trials
1. What is a clinical trial?
A clinical trial is a carefully designed study which tests the benefits and risks of a specific medical treatment or intervention, such as a new drug. Every life-saving or life-enhancing medicine that is helping patients today once was the focus of a clinical trial.
2. Drugs go through a long journey before getting approved by the FDA.
3. There are currently 257,799 research studies in all 50 states and in 201 countries listed on clinicaltrials.gov.
ClinicalTrials.gov is a Web-based resource that provides patients, their family members, health care professionals, researchers, and the public with easy access to information on publicly and privately supported clinical studies on a wide range of diseases and conditions. The Web site is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH).
4. What is a placebo?
A placebo is an inactive pill, liquid, or powder that has no treatment value. In clinical trials, experimental treatments are compared with placebos to assess the treatment’s effectiveness. In some studies, the participants in the control group will receive a placebo instead of an active drug or treatment.
5. Not every clinical trial involves investigational medication.
Different types of clinical trials include:
Quality of Life trials
Clinical research trainings are given to every professional involved in the trial. Clinical research trainings are continuously updated based on the disease and development of technology to ensure the complete safety of the participants of the trial.